Dashboard
Weak Long Term Fundamental Strength with a 18.02% CAGR growth in Operating Profits
Positive results in Sep 26
Stock is technically in a Bullish range
With ROE of 35.9, it has a Very Expensive valuation with a 8.2 Price to Book Value
Majority shareholders : Non Institution
Market Beating performance in long term as well as near term
Stock DNA
Non Banking Financial Company (NBFC)
INR 18 Cr (Micro Cap)
23.00
20
0.00%
0.00
35.94%
8.57
Total Returns (Price + Dividend) 
Nexus Surgical for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Nexus Surgical and Medicare Ltd Reports Positive Financial Trend Amid Margin Pressures
Nexus Surgical and Medicare Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has demonstrated a notable shift in its financial trend from flat to positive in the quarter ended September 2026. Despite some operational challenges reflected in quarterly profit metrics, the company’s revenue growth and year-to-date returns have outpaced broader market benchmarks, signalling a potential turnaround in its business trajectory.
Read More
Broad-Based Technical Strength Lifts Nexus Surgical and Medicare Ltd to 52-Week High of Rs 29.9
Surging to an intraday peak of Rs 29.9 on 7 Sep 2026, Nexus Surgical and Medicare Ltd has marked a significant milestone by reaching a new 52-week high. This achievement comes amid a backdrop of strong technical momentum, with the stock outperforming its sector by over 10% on the day despite a volatile session.
Read More Announcements 
Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday 14Th November 2026
14-Nov-2026 | Source : BSESubmission of Outcome of Board Meeting held on Saturday 14th November 2026
Results - Financial Results For 30-09-2026
14-Nov-2026 | Source : BSESubmission of Unaudited Quarterly Financial Results of the Company for the quarter and half year ended 30th September 2026
Board Meeting Intimation for Notice Of Board Meeting Scheduled To Be Held On Saturday 14Th November 2026
05-Nov-2026 | Source : BSENexus Surgical And Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 inter alia to consider and approve 1. the Unaudited Quarterly Financial Results of the Company for the quarter and half year ended 30th September 2026
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
Mildred Mercantile Private Limited (18.55%)
Harivardhan Steel & Alloys Private Limited (16.35%)
42.38%
Quarterly Results Snapshot (Standalone) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is 45.49% vs 24.39% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is -15.00% vs -16.67% in Jun 2026
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 4.71% vs 93.01% in Sep 2024
Growth in half year ended Sep 2025 is 10.00% vs 172.73% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 37.26% vs 47.22% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 21.95% vs 156.25% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 37.59% vs 64.84% in Mar 2025
YoY Growth in year ended Mar 2026 is 48.00% vs 138.10% in Mar 2025